NCT04094428 Burden, Mortality and Supply Costs in Intensive Care Unit Patients
| NCT ID | NCT04094428 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Ulm |
| Condition | Burden, Dependency |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2019-10-21 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2019-10-21 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study systematically observes in a pragmatic trail under real world conditions the association between strategies of therapy (maximal therapy, withhold, withdraw) and treatment success in three endpoint related initial risk groups (high, intermediate, low risk) regarding three endpoints (burden, mortality and supply costs).
Eligibility Criteria
Inclusion Criteria: * All patients dying on the ICU and all patients staying for at least 72 hours on the ICU Exclusion Criteria: * No
Contact & Investigator
Manfred Weiss, MD, MBA
PRINCIPAL INVESTIGATOR
University Hospital Medical School
Frequently Asked Questions
Who can join the NCT04094428 clinical trial?
This trial is open to participants of all sexes, studying Burden, Dependency. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04094428 currently recruiting?
Yes, NCT04094428 is actively recruiting participants. Contact the research team at manfred.weiss@uniklinik-ulm.de for enrollment information.
Where is the NCT04094428 trial being conducted?
This trial is being conducted at Ulm, Germany.
Who is sponsoring the NCT04094428 clinical trial?
NCT04094428 is sponsored by University of Ulm. The principal investigator is Manfred Weiss, MD, MBA at University Hospital Medical School. The trial plans to enroll 700 participants.